Background: Millimeter-wave directed energy (mmWave DE) is increasingly used in telecommunications and military applications, yet its biological effects remain unclear. Here, we characterized the spatially dependent cellular and molecular impacts of 34.14 GHz mmWave DE exposure on mouse neuroblastoma (N2A) cells. Methods: N2A cells were exposed to mmWave DE for 48 h, generating Center (direct exposure), Penumbra (peripheral exposure), and Control groups. Morphology was assessed by phase-contrast microscopy and F-actin staining; viability and membrane integrity were evaluated by MTT, LDH, and DAPI/PI assays. Cytoskeletal protein degradation (αII-Spectrin, Vimentin, Nestin) was examined by Western blot and immunocytochemistry. Label-free LC-MS/MS proteomics, Gene Ontology (GO), Ingenuity Pathway Analysis (IPA), and PathwayStudio were used to define global molecular responses. Results: Center-exposed cells showed severe morphological disruption, reduced viability ( p < 0.0001), increased LDH release, and marked membrane permeabilization, consistent with dominant necrotic injury. Western blotting revealed enhanced proteolysis of αII-Spectrin, Vimentin, and Nestin. Proteomic profiling identified 181 statistically significant dysregulated proteins in the Center and 34 in the Penumbra (adjusted p < 0.05); of these, 12 and 14 proteins, respectively, also met the high-effect threshold of |log₂FC| ≥ 1. These alterations converged on cytoskeletal organization, mitochondrial stress, RNA processing, and proteostasis. Conclusion: mmWave DE exposure induces a spatially graded injury response, ranging from adaptive stress signaling in the Penumbra to proteostasis collapse, cytoskeletal failure, and membrane injury in the Center. These findings support further mechanistic evaluation of mmWave bioeffects and their potential relevance to neuroinjury-related pathways.